Biodesix Entered Into A New Master Collaborative Research Agreement With Memorial Sloan Kettering Cancer Center Under Which The Teams Will Collaborate On A Development Plan For Diagnostic Tests For Cancer
Author: Benzinga Newsdesk | March 25, 2024 06:08am
Biodesix will utilize its array of genomics, proteomics, and data mining capabilities with the aim of developing and commercializing oncology biomarker assays in collaboration with MSK. Bio-Rad will provide its digital PCR assay technology.
Posted In: BDSX